Amyloid fibrils formed from a segment of the pancreatic islet amyloid protein.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMID 3048259)

Published in Biochem Biophys Res Commun on September 15, 1988

Authors

G G Glenner1, E D Eanes, C A Wiley

Author Affiliations

1: University of California, San Diego, La Jolla 92093.

Articles citing this

Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. Biochemistry (2007) 3.57

Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A (1990) 3.29

Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci U S A (1996) 1.80

Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc Natl Acad Sci U S A (1993) 1.68

Conservation of the sequence of islet amyloid polypeptide in five mammals is consistent with its putative role as an islet hormone. Proc Natl Acad Sci U S A (1989) 1.25

Low levels of asparagine deamidation can have a dramatic effect on aggregation of amyloidogenic peptides: implications for the study of amyloid formation. Protein Sci (2002) 1.20

Mechanism of IAPP amyloid fibril formation involves an intermediate with a transient β-sheet. Proc Natl Acad Sci U S A (2013) 1.20

Rat amylin: cloning and tissue-specific expression in pancreatic islets. Proc Natl Acad Sci U S A (1989) 1.14

Solution state structures of human pancreatic amylin and pramlintide. Protein Eng Des Sel (2009) 1.00

Micelle formation by a fragment of human islet amyloid polypeptide. Biophys J (2003) 0.94

Amyloidogenesis abolished by proline substitutions but enhanced by lipid binding. PLoS Comput Biol (2009) 0.91

Beta structure motifs of islet amyloid polypeptides identified through surface-mediated assemblies. Proc Natl Acad Sci U S A (2011) 0.84

Alzheimer's disease and type 2 diabetes via chronic inflammatory mechanisms. Saudi J Biol Sci (2014) 0.84

Effect of proline mutations on the monomer conformations of amylin. Biophys J (2013) 0.83

Unique example of amyloid aggregates stabilized by main chain H-bond instead of the steric zipper: molecular dynamics study of the amyloidogenic segment of amylin wild-type and mutants. J Mol Model (2011) 0.83

Spontaneous diabetes in hemizygous human amylin transgenic mice that developed neither islet amyloid nor peripheral insulin resistance. Diabetes (2008) 0.83

The role of the 14-20 domain of the islet amyloid polypeptide in amyloid formation. Exp Diabetes Res (2008) 0.81

Apolipoprotein E includes a binding site which is recognized by several amyloidogenic polypeptides. Biochem J (2000) 0.77

Design and Optimization of Anti-amyloid Domain Antibodies Specific for β-Amyloid and Islet Amyloid Polypeptide. J Biol Chem (2015) 0.76

Two-dimensional sum-frequency generation (2D SFG) spectroscopy: summary of principles and its application to amyloid fiber monolayers. Faraday Discuss (2015) 0.75

Matrix Metalloproteinase-9 Protects Islets from Amyloid-induced Toxicity. J Biol Chem (2015) 0.75

Caloric intake, dietary lifestyles, macronutrient composition, and alzheimer' disease dementia. Int J Alzheimers Dis (2011) 0.75

Sequence-Dependent Self-Assembly and Structural Diversity of Islet Amyloid Polypeptide-Derived β-Sheet Fibrils. ACS Nano (2017) 0.75

Articles by these authors

(truncated to the top 100)

Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A (1986) 8.45

X-ray diffraction studies on amyloid filaments. J Histochem Cytochem (1968) 4.54

Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol (1997) 3.38

Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet (1988) 3.21

Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology (1992) 3.15

Creation of "amyloid" fibrils from Bence Jones proteins in vitro. Science (1971) 3.14

Dental composites based on hybrid and surface-modified amorphous calcium phosphates. Biomaterials (2003) 2.95

Beta-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem (1974) 2.69

Physicochemical evaluation of bioactive polymeric composites based on hybrid amorphous calcium phosphates. J Biomed Mater Res (2000) 2.61

Quantitative assessment of the efficacy of amorphous calcium phosphate/methacrylate composites in remineralizing caries-like lesions artificially produced in bovine enamel. J Dent Res (1996) 2.49

X-ray diffraction studies of the sulfur globules accumulated by Chromatium species. J Bacteriol (1970) 2.22

Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol (1992) 2.21

Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest (1992) 2.12

Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in an AIDS patient. J Neuropathol Exp Neurol (1986) 1.94

Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem (1995) 1.86

Intermediate states in the precipitation of hydroxyapatite. Nature (1965) 1.84

Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections. J Virol (1988) 1.83

HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol (1991) 1.81

HIV and HCMV coinfect brain cells in patients with AIDS. Virology (1988) 1.65

Chemokines and receptors in HIV encephalitis. AIDS (1998) 1.59

Coexistence of rigid crystalline and liquid crystalline phases in lecithin-water mixtures. Biophys J (1974) 1.58

Setting reactions and compressive strengths of calcium phosphate cements. J Dent Res (1990) 1.56

Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol (1992) 1.51

The amyloid deposits in Alzheimer's disease: their nature and pathogenesis. Appl Pathol (1984) 1.49

Human amyloid protein: chemical variability and homogeneity. J Histochem Cytochem (1971) 1.45

Intraocular tolerance of perfluorooctylbromide (perflubron) Retina (1995) 1.44

HTLV-1 in acquired adult myopathy. Muscle Nerve (1993) 1.42

Microradiographic study of the calcified layer of articular cartilage. Arch Pathol (1970) 1.41

T-cell-induced expression of human immunodeficiency virus in macrophages. J Virol (1990) 1.38

Improved properties of amorphous calcium phosphate fillers in remineralizing resin composites. Dent Mater (1996) 1.37

Hydrazine-deproteinated bone mineral. Physical and chemical properties. Calcif Tissue Res (1973) 1.37

Enzyme-linked immunosorbent assay for detection of specific antibodies to Ureaplasma urealyticum serotypes. J Clin Microbiol (1984) 1.33

Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem J (1996) 1.32

The relation of the properties of Congo red-stained amyloid fibrils to the -conformation. J Histochem Cytochem (1972) 1.32

Phosphoprotein modulation of apatite crystallization. Calcif Tissue Int (1980) 1.29

Influence of electrolytes on the thicknesses of the phospholipid bilayers of lamellar lecithin mesophases. Biophys J (1972) 1.27

Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol (2004) 1.26

Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J Clin Invest (1993) 1.25

Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques. FASEB J (1998) 1.23

Mechanisms of immune activation of human immunodeficiency virus in monocytes/macrophages. J Virol (1993) 1.22

Physical and chemical properties of amyloid fibers. II. Isolation of a unique protein constituting the major component from human splenic amyloid fibril concentrates. J Histochem Cytochem (1969) 1.21

Role of opportunistic viral infections in AIDS. AIDS (1990) 1.19

A thermodynamic analysis of the secondary transition in the spontaneous precipitation of calcium phosphate. Calcif Tissue Res (1978) 1.18

Brain viral burden in HIV infection. J Neuropathol Exp Neurol (1994) 1.18

Sequence analysis of the V3 loop in brain and spleen of patients with HIV encephalitis. AIDS Res Hum Retroviruses (1996) 1.18

Murine amyloid fibril protein: isolation, purification and characterization. J Histochem Cytochem (1971) 1.17

Spontaneous precipitation of brushite in urine: evidence that brushite is the nidus of renal stones originating as calcium phosphate. Proc Natl Acad Sci U S A (1971) 1.15

Comparative chemistry of amorphous and apatitic calcium phosphate preparations. Calcif Tissue Res (1972) 1.15

Cultured human brain capillary endothelial cells are permissive for infection by human cytomegalovirus. Virology (1990) 1.13

Infrared spectroscopy of human amyloid fibrils and immunoglobulin proteins. Biopolymers (1972) 1.13

Silica- and zirconia-hybridized amorphous calcium phosphate: effect on transformation to hydroxyapatite. J Biomed Mater Res (2002) 1.12

Thermochemical studies on amorphous calcium phosphate. Calcif Tissue Res (1970) 1.10

An electron microscopic study of the formation of amorphous calcium phosphate and its transformation to crystalline apatite. Calcif Tissue Res (1973) 1.10

The relationship of quantitative brain magnetic resonance imaging measures to neuropathologic indexes of human immunodeficiency virus infection. Arch Neurol (1994) 1.09

Amyloid. VI. A comparison of two morphologic components of human amyloid deposits. J Histochem Cytochem (1968) 1.08

Changes in apatite crystal size in bones of patients with osteogenesis imperfecta. Calcif Tissue Int (1991) 1.07

X-ray diffraction study of the mineralization of turkey leg tendon. Calcif Tissue Res (1970) 1.07

Encephalitis caused by human immunodeficiency virus: CT and MR imaging manifestations with clinical and pathologic correlation. Radiology (1990) 1.07

Pathogenic and protective correlates of T cell proliferation in AIDS. HNRC Group. HIV Neurobehavioral Research Center. J Clin Invest (1996) 1.07

HTLV-I-associated myelopathy: clinicopathologic correlation with localization of provirus to spinal cord. Neurology (1991) 1.06

Hereditary joint disorder in progressive ankylosis (ank/ank) mice. I. Association of calcium hydroxyapatite deposition with inflammatory arthropathy. Arthritis Rheum (1984) 1.06

Tyramide signal amplification method in multiple-label immunofluorescence confocal microscopy. Methods (1999) 1.05

Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis. Am J Pathol (2000) 1.05

A thermodynamic analysis of the amorphous to crystalline calcium phosphate transformation. Calcif Tissue Res (1978) 1.02

Characterization of native and recombinant bone sialoprotein: delineation of the mineral-binding and cell adhesion domains and structural analysis of the RGD domain. J Bone Miner Res (1997) 1.02

Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group. J Clin Invest (1995) 1.01

Atypical healing of cytomegalovirus retinitis. Significance of persistent border opacification. Ophthalmology (1992) 1.01

Malignant phyllodes tumor of the prostate. A case report with immunohistochemical and ultrastructural studies. Arch Pathol Lab Med (1992) 1.00

The maturation of crystalline calcium phosphates in aqueous suspensions at physiologic pH. Calcif Tissue Res (1977) 1.00

Endoretinal biopsy in immunosuppressed and healthy patients with retinitis. Indications, utility, and techniques. Ophthalmology (1989) 1.00

Rows of dimeric-particles within the axolemma and juxtaposed particles within glia, incorporated into a new model for the paranodal glial-axonal junction at the node of Ranvier. J Cell Biol (1980) 0.99

Intermediate phases in the basic solution preparation of alkaline earth phosphates. Calcif Tissue Res (1968) 0.97

On phase transitions in erythrocyte membranes and extracted membrane lipids. Biochim Biophys Acta (1974) 0.97

Expression of HGF and cMet in the developing and adult brain. Brain Res Dev Brain Res (1997) 0.97

Behavior of a calcium phosphate cement in simulated blood plasma in vitro. Dent Mater (1994) 0.96

Herpesviruses in chronic encephalitis associated with intractable childhood epilepsy. Hum Pathol (1993) 0.96

The hydrolysis of anhydrous dicalcium phosphate into hydroxyapatite. J Dent Res (1993) 0.95

Expression of major histocompatibility complex antigens in the brains of patients with progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol (1992) 0.95

Intravitreal toxicology in rabbits of two preparations of 1-O-octadecyl-sn-glycerol-3-phosphonoformate, a sustained-delivery anti-CMV drug. Invest Ophthalmol Vis Sci (1999) 0.94

Collagen crosslinks and mineral crystallinity in bone of patients with osteogenesis imperfecta. J Bone Miner Res (1993) 0.94

Differential vulnerability of calbindin-immunoreactive neurons in HIV encephalitis. J Neuropathol Exp Neurol (1995) 0.93

The cerebellum in sagittal plane--anatomic-MR correlation: 1. The vermis. AJR Am J Roentgenol (1989) 0.93

Patterns of neurodegeneration in HIV encephalitis. J NeuroAIDS (1996) 0.92

Brain HIV burden and length of survival after AIDS diagnosis. Clin Neuropathol (1998) 0.92

Role of HIV and CMV in the pathogenesis of retinitis and retinal vasculopathy in AIDS patients. Invest Ophthalmol Vis Sci (1992) 0.92

Immunohistochemical localization of neurotropic ecotropic murine leukemia virus in moribund mice. Virology (1990) 0.92

Spinal cord and peripheral nerve pathology in AIDS: the roles of cytomegalovirus and human immunodeficiency virus. Ann Neurol (1989) 0.92

Enamel apatite: chemistry, structure and properties. J Dent Res (1979) 0.91

In vitro precipitation of calcium phosphate under intracellular conditions: formation of brushite from an amorphous precursor in the absence of ATP. Calcif Tissue Int (1985) 0.91

Miliary toxoplasmic retinitis in acquired immunodeficiency syndrome. Arch Ophthalmol (1993) 0.91

Expression of major histocompatibility complex and HIV antigens within the brains of AIDS patients. AIDS (1991) 0.91

Development of spongiform encephalopathy in retroviral infected mice. Lab Invest (1992) 0.90

Degeneration of oxidative muscle fibers in HTLV-1 tax transgenic mice. Am J Pathol (1989) 0.90

Inflammation in AIDS and the role of the macrophage in brain pathology. Curr Opin Neurol (1996) 0.90

Detection of cytomegalovirus in cerebrospinal fluid autopsy specimens from AIDS patients. J Infect Dis (1994) 0.90

A critical evaluation of the purification of biominerals by hypochlorite treatment. J Biomed Mater Res (1993) 0.89

Acanthamoeba meningoencephalitis in a patient with AIDS. J Infect Dis (1987) 0.89

Response of cell cycle proteins to neurotrophic factor and chemokine stimulation in human neuroglia. Exp Neurol (2001) 0.89

Inhibition of seeded growth of enamel apatite crystals by amelogenin and enamelin proteins in vitro. J Dent Res (1984) 0.89

The cerebellum in sagittal plane--anatomic-MR correlation: 2. The cerebellar hemispheres. AJR Am J Roentgenol (1989) 0.87